AKUMS - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 3.3

📊 Technical & Momentum Analysis

Price vs DMA: Currently trading below both 50-DMA (₹494) and 200-DMA (₹561), indicating short-term weakness and lack of bullish confirmation.

RSI (47.9): Neutral zone—neither oversold nor showing strength. No momentum signal.

MACD (-7.36): Bearish crossover—momentum is fading.

Volume: Significantly below 1-week average, suggesting weak participation and low conviction.

📈 Fundamental Snapshot

Metric Value Interpretation

P/E 45.6 Overvalued vs industry PE (33.4)

PEG Ratio 1.33 Fairly priced relative to growth—acceptable for tactical swing

ROCE / ROE 16.2% / 13.2% Decent capital efficiency—supports quality setup

Debt-to-Equity 0.02 Virtually debt-free—financially sound

PAT Growth (QoQ) +62.7% Strong earnings momentum—positive sentiment driver

FII/DII Change -1.53% / +1.46% DII inflow offsets FII trimming—net neutral sentiment

🧠 Swing Trade Logic

Bias: Fundamentally stable with improving earnings, but technically weak.

Catalyst: PAT growth and DII accumulation offer support, but MACD and volume lack confirmation.

Risk: Weak momentum and low volume—entry should be delayed until reversal signals appear.

🎯 Optimal Entry Price

Buy Zone: ₹460–₹470

(Near short-term support with stop-loss below ₹445)

🚪 Exit Strategy

If Already Holding

Target Exit: ₹495–₹510 (Resistance near 50-DMA and prior swing zone)

Stop-Loss: ₹445 (Below MACD base and recent support)

Selva, this setup is best treated as a watchlist candidate until momentum confirms. If you're building a pharma or mid-cap basket, I can scan for peers with better PEG alignment and breakout overlays. Let’s refine that layer when you’re ready.

Edit in a page